作者: Toshiya Inada , Ataru Inagaki
DOI: 10.1111/PCN.12275
关键词: Psychotropic Agent 、 Antiparkinsonian drugs 、 Randomized controlled trial 、 Medical prescription 、 Equivalence (measure theory) 、 Psychiatry 、 Medicine 、 Therapeutic equivalency 、 Racial differences 、 Antipsychotic
摘要: Psychotropic dose equivalence is an important concept when estimating the approximate psychotropic doses patients receive, and deciding on titration switching from one agent to another. It also useful a research viewpoint defining extracting specific subgroups of subjects. Unification various agents into single standard facilitates easier analytical comparisons. On basis differences in psychopharmacological prescription features, those available their approved doses, racial between Japan other countries, equivalency tables designed specifically for Japanese have been widely used since 1998. Here we introduce for: (i) antipsychotics; (ii) antiparkinsonian agents; (iii) antidepressants; (iv) anxiolytics, sedatives hypnotics Japan. Equivalent therapeutic effects individual compounds were determined principally randomized controlled trials conducted consensus among reported previously by experts. As these are intended merely suggest values, physicians should use them with discretion. Updated information at http://www.jsprs.org/en/equivalence.tables/. [Correction added 8 July 2015, after first online publication: A link updated has added.].